HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.

AbstractBACKGROUND:
Prevalence of neurocognitive impairment in HIV-1 infected patients is reported to be high. Whether this is a result of active HIV-related neurodegeneration is unclear. We examined axonal injury in HIV-1 patients by measuring the light subunit of neurofilament protein (NFL) in CSF with a novel, sensitive method.
METHODS:
With a cross-sectional design, CSF concentrations of neurofilament protein light (NFL) (marker of neuronal injury), neopterin (intrathecal immunoactivation) and CSF/Plasma albumin ratio (blood-brain barrier integrity) were analyzed on CSF from 252 HIV-infected patients, subdivided into untreated neuroasymptomatics (n = 200), HIV-associated dementia (HAD) (n = 14) and on combinations antiretroviral treatment (cART) (n = 85), and healthy controls (n = 204). 46 HIV-infected patients were included in both treated and untreated groups, but sampled at different timepoints. Furthermore, 78 neuroasymptomatic patients were analyzed before and after treatment initiation.
RESULTS:
While HAD patients had the highest NFL concentrations, elevated CSF NFL was also found in 33% of untreated neuroasymptomatic patients, mainly in those with blood CD4+ cell counts below 250 cells/μL. CSF NFL concentrations in the untreated neuroasymptomatics and treated groups were equivalent to controls 18.5 and 3.9 years older, respectively. Neopterin correlated with NFL levels in untreated groups while the albumin ratio correlated with NFL in both untreated and treated groups.
CONCLUSIONS:
Increased CSF NFL indicates ongoing axonal injury in many neuroasymptomatic patients. Treatment decreases NFL, but treated patients retain higher levels than controls, indicating either continued virus-related injury or an aging-like effect of HIV infection. NFL correlates with neopterin and albumin ratio, suggesting an association between axonal injury, neuroinflammation and blood-brain barrier permeability. NFL appears to be a sensitive biomarker of subclinical and clinical brain injury in HIV and warrants further assessment for broader clinical use.
AuthorsJan Jessen Krut, Tomas Mellberg, Richard W Price, Lars Hagberg, Dietmar Fuchs, Lars Rosengren, Staffan Nilsson, Henrik Zetterberg, Magnus Gisslén
JournalPloS one (PLoS One) Vol. 9 Issue 2 Pg. e88591 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID24523921 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Neurofilament Proteins
  • neurofilament protein L
  • Neopterin
Topics
  • AIDS Dementia Complex (cerebrospinal fluid)
  • Adult
  • Axons (pathology)
  • Biomarkers (metabolism)
  • CD4-Positive T-Lymphocytes (cytology)
  • Case-Control Studies
  • Cognition Disorders (cerebrospinal fluid, complications)
  • Cross-Sectional Studies
  • HIV Infections (cerebrospinal fluid, complications)
  • HIV-1
  • Humans
  • Longitudinal Studies
  • Middle Aged
  • Neopterin (cerebrospinal fluid)
  • Neurofilament Proteins (cerebrospinal fluid)
  • Neurons (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: